Description

5-[4-[(2S)-2-(1H-Benzimidazol-2-Yl)-2-(2-Benzothiazolylamino)Ethyl]-2-Fluorophenyl]-3-Isothiazolidinone 1,1-Dioxide is a high-purity, complex heterocyclic compound designed for advanced research and development. This molecule is valued for its sophisticated structure, which incorporates benzimidazole, benzothiazole, and isothiazolidinone moieties, making it a key intermediate in the synthesis of novel active pharmaceutical ingredients (APIs). It is primarily sought by pharmaceutical R&D teams and fine chemical manufacturers focused on developing new therapeutic agents, particularly in areas requiring high structural specificity and purity.

Application

• Pharmaceutical Intermediate: Serves as a critical building block in the synthesis of novel drug candidates, especially those targeting specific enzymatic pathways.
• Biochemical Research: Used as a reference standard or a probe molecule in studying protein-ligand interactions and enzyme inhibition assays.
• Organic Synthesis: Acts as a versatile precursor for constructing more complex heterocyclic systems in medicinal chemistry.
• Agrochemical Development: Potential use in the research and development of new crop protection agents with unique modes of action.
• Material Science Research: Investigated for the development of specialty polymers or organic electronic materials due to its conjugated structure.

Basic Information

Product Name	5-[4-[(2S)-2-(1H-Benzimidazol-2-Yl)-2-(2-Benzothiazolylamino)Ethyl]-2-Fluorophenyl]-3-Isothiazolidinone 1,1-Dioxide
CAS No.	850321-90-3
Molecular Formula	C25H21FN6O3S2
Molecular Weight	544.60 g/mol
Synonyms	5-[4-[(2S)-2-(1H-Benzimidazol-2-yl)-2-[(2-benzothiazolyl)amino]ethyl]-2-fluorophenyl]-3-isothiazolidinone 1,1-dioxide; (2S)-N-(2-Benzothiazolyl)-2-(1H-benzimidazol-2-yl)-2-[4-(1,1-dioxido-3-oxo-4-isothiazolidinyl)-3-fluorophenyl]ethanamine; CAS 850321-90-3; UNII-6F8J4W2306; 6F8J4W2306; Benzimidazole-benzothiazole-isothiazolidinone derivative; SCHEMBL15445097; AOB34017.
EINECS	Contact for details

Quality Control

Our production of 5-[4-[(2S)-2-(1H-Benzimidazol-2-Yl)-2-(2-Benzothiazolylamino)Ethyl]-2-Fluorophenyl]-3-Isothiazolidinone 1,1-Dioxide adheres to stringent quality management protocols. Each batch undergoes comprehensive analytical testing, including HPLC for purity, chiral analysis for enantiomeric excess, and spectroscopic identification (NMR, MS). Certificates of Analysis (COA) detailing all specifications are provided to ensure traceability and compliance with your research or cGMP starting material requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). The compound is light-sensitive (store away from light). Keep the container tightly sealed in a dry environment to prevent moisture absorption.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (HPLC)	Conforms
Identification (IR)	Conforms to reference spectrum
Purity (HPLC)	≥ 98.0%
Chiral Purity (Chiral HPLC)	≥ 99.0% ee
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.